The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast
ISSN
09546820
Date Issued
2022
DOI
10.1111/joim.13447
Subjects